|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/37 | (2006.01) |
| A61K 38/37 | (2013.01) | ||
| A61P 7/04 | (2006.01) | ||
| A61P 7/04 | (2018.01) |
| (11) | Patento numeris | 3193911 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15741222.2 |
| Europos patento paraiškos padavimo data | 2015-07-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-07-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-09-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2015/067014 |
| Data | 2015-07-24 |
| (87) | Numeris | WO 2016/012595 |
| Data | 2016-01-28 |
| (30) | Numeris | Data | Šalis |
| 14178563 | 2014-07-25 | EP |
| (72) |
SCHMIDBAUER, Stefan , DE
METZNER, Hubert , DE
ROBBEL, Lars , DE
|
| (73) |
CSL Behring GmbH ,
Emil-von-Behring-Strasse 76, 35041 Marburg,
DE
|
| (54) | IMPROVED FACTOR VIII PREPARATIONS FOR USE IN TREATING HEMOPHILIA A |
| IMPROVED FACTOR VIII PREPARATIONS FOR USE IN TREATING HEMOPHILIA A |